Ragweed allergy vaccine sublingual - Greer Laboratories

Drug Profile

Ragweed allergy vaccine sublingual - Greer Laboratories

Alternative Names: SAIL™ standardized short ragweed extract; Short ragweed extract immunotherapy - Greer Laboratories; Sublingual Allergy Immunotherapy Liquid

Latest Information Update: 11 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Greer Laboratories
  • Class Allergens; Antiallergics; Plant allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Seasonal allergic rhinitis

Most Recent Events

  • 14 May 2015 No recent reports on development identified - Phase-III for Seasonal allergic rhinitis in USA (Sublingual)
  • 10 Mar 2014 Development of the sublingual ragweed allergy vaccine is ongoing
  • 25 Feb 2013 Additional efficacy & adverse events data from a phase III trial in Seasonal allergic rhinitis presented at the Annual Meeting of the American Academy of Allergy Asthma & Immunology (AAAAI-2013)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top